✦ LIBER ✦

592 First-in-human Phase 0 Trial of Oral 5-iodo-2-pyrimidinone-2′-deoxyribose (IPdR) in Patients with Advanced Malignancies

✍ Scribed by Kummar, S.; Anderson, L.; Hill, K.; Majerova, E.; Allen, D.; Horneffer, Y.; Ivy, P.; Harris, P.; Doroshow, J.H.; Collins, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-in-human phase 1/2a trial of CRLX1

✍ Glen J. Weiss, Joseph Chao, Jeffrey D. Neidhart, Ramesh K. Ramanathan, Dawn Bass 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 823 KB

Phase I trial of high-dose infusional hy

✍ Scott Wadler; Hilda Haynes; Richard Schechner; Alla Rozenblit; Peter H. Wiemik 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 547 KB

A first-in-class, first-in-human, phase

✍ Warso, M A; Richards, J M; Mehta, D; Christov, K; Schaeffer, C; Rae Bressler, L; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 748 KB

314 Biomarker Analysis in the First-in-h

✍ Tolcher, A.; Kapoun, A.M.; Wang, M.; Zhang, C.; Patnaik, A.; Papadopoulos, K.; C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB